Mattia Galli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease	ANNALS OF INTERNAL MEDICINE	2023
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs. without left ventricular unloading by Impella: a systematic review and meta-analysis	EUROPEAN HEART JOURNAL. QUALITY OF CARE & CLINICAL OUTCOMES	2023
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis	INTERNATIONAL JOURNAL OF CARDIOLOGY	2023
Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome	EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY	2023
Factor XI inhibitors in early clinical trials. A meta-analysis	THROMBOSIS AND HAEMOSTASIS	2023
Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2023
Eligibility for the 4 Pharmacological Pillars in Heart Failure With Reduced Ejection Fraction at Discharge	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2023
Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention	TRENDS IN CARDIOVASCULAR MEDICINE	2023
Cangrelor in patients with coronary artery disease pretreated with tagrelor. The switching antiplatelet (SWAP)-5 study	JACC: CARDIOVASCULAR INTERVENTIONS	2023
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications	EXPERT REVIEW OF CLINICAL PHARMACOLOGY	2023
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study	JACC: CARDIOVASCULAR INTERVENTIONS	2023
Device‐based remote monitoring strategies for congestion‐guided management of patients with heart failure: a systematic review and meta‐analysis	EUROPEAN JOURNAL OF HEART FAILURE	2022
Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2022
De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?	FRONTIERS IN CARDIOVASCULAR MEDICINE	2022
Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention	REVIEWS IN CARDIOVASCULAR MEDICINE	2022
The Role of Antiplatelet Therapy in Patients With MINOCA	FRONTIERS IN CARDIOVASCULAR MEDICINE	2022
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week	EUROPEAN HEART JOURNAL	2022
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19. A systematic review and meta-analysis of randomized controlled trials	EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY	2022
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week (August, ehac294, 2022)	EUROPEAN HEART JOURNAL	2022
Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention	PHARMACOGENOMICS	2022